Filing Flows › Cerenome (CNSY) › Q3 2025
Cerenome (CNSY) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 30, 2025
Cerenome (CNSY) reported revenue of $1.4M for the third quarter 2025 (Q3 2025), -4% from a year earlier and +0.5% from the quarter before. Operating margin was -320.8%, net loss $4.4M (316.6% of revenue).
Cerenome, Q3 2025: revenue $1.4M (-4% year over year), operating margin -320.8%, net loss $4.4M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | +0.5% | -4% |
| Operating profit | −$4.5M | — | — |
| Net earnings | −$4.4M | -186% | — |
| Operating cash flow | −$2.5M | — | — |
What changed
Revenue was $1.4M in Q3 2025, down 4% year over year and up 1% from the previous quarter.
Operating costs exceeded revenue by $4.5M, an operating margin of -320.8%. Total costs grew 12% against a revenue fall of 4%. The fastest-growing cost line was General & admin (+44%). The quarter ended with a net loss of $4.4M, after a profit of $5.2M the previous quarter.
Operating cash flow was −$2.5M. Non-cash charges added back $77K of depreciation and amortization and $527K of share-based compensation. Working capital and other items added $1.3M. Capital expenditures of $27K exceeded it, leaving free cash flow of −$2.6M.
Questions
What was Cerenome's revenue in the third quarter 2025?
Cerenome (CNSY) reported revenue of $1.4M for the third quarter 2025 (Q3 2025), -4% from a year earlier and +0.5% from the quarter before.
Was Cerenome profitable in the third quarter 2025?
Operating loss was $4.5M (-320.8% of revenue) and net loss $4.4M.
Source: Cerenome 10-Q on SEC EDGAR.